Phase 2 Study of Second-Line Dovitinib (Tki258) in Patients with Fibroblast Growth Factor Receptor 2 (Fgfr2)-Mutated or -Nonmutated Advanced and/or Metastatic Endometrial Cancer
G.E. Konecny
◽
N. Finkler
◽
A.A. Garcia
◽
D. Lorusso
◽
P. Lee
◽
...
Nick C. Turner
◽
Ian E. Krop
◽
Aditya Bardia
◽
Senthil Damodaran
◽
Miguel Martin
◽
...
2016 ◽
Vol 27
◽
pp. vi293
◽
A.O. Siefker-Radtke
◽
B. Mellado
◽
K. Decaestecker
◽
J.M. Burke
◽
A. O'Hagan
◽
...
Luis Féliz
◽
Ekaterine Asatiani
◽
Christine Lihou
◽
Huiling Zhen
◽
Ian Silverman
◽
...
2021 ◽
Vol 16
(3)
◽
pp. S673
S. Pant
◽
J. Tabernero
◽
C. Massard
◽
D.M. Hyman
◽
O. Witt
◽
...
A Sengal
◽
E Williams
◽
J McAlpine
◽
P Pollock
2013 ◽
Vol 12
(5)
◽
pp. 632-642
◽
Gottfried E. Konecny
◽
Teodora Kolarova
◽
Neil A. O'Brien
◽
Boris Winterhoff
◽
Guorong Yang
◽
...
2020 ◽
Vol 138
◽
pp. S25-S26
P. Mcsheehy
◽
J. Boult
◽
S. Robinson
◽
F. Bachmann
◽
M. El Shemerly
◽
...
Sara A. Byron
◽
David C. Loch
◽
Pamela M. Pollock
2017 ◽
Vol 17
◽
pp. S350-S351
◽
Srdan Verstovsek
◽
Alessandro Rambaldi
◽
Christine Lihou
◽
Huiling Zhen
◽
Andreas Hochhaus
Sebastien Taurin
◽
Chieh-Hsiang Yang
◽
Maria Reyes
◽
Sungpil Cho
◽
Elke A. Jarboe
◽
...
Close
Export Citation Format
Close
Share Document
Close